Sir,
We read with great interest Andrijević Derk et al1manuscript on medical therapy for uveal effusion syndrome (UES) and wish to add our suggestions whether surgical intervention is required. A number of surgical procedures have been described for the management of UES.2 Herein, we describe our surgical management of a case of UES, demonstrating the global nature of the ocular pathology.
Case report
A 29-year-old man presented with a 2-week history of decreased vision in the right eye, on the background of poor ipsilateral vision for the past 2 years. He had no significant ocular or medical history. His visual acuity was right 20/200 and left 20/15. Intraocular pressures were right 13 mm Hg and left 14 mm Hg. Examination of the right ocular fundus showed inferior retinal detachment (Figure 1a). No retinal breaks were found, and this was deemed exudative in aetiology. There was no intraocular inflammation. B-scan ultrasonography demonstrated thickened sclera, with no posterior segment mass. Optical coherence tomography demonstrated fluid under the macula (Figure 1a). The axial length was 20.46 mm in the right eye and 21.88 mm in the left eye. The left eye was unremarkable.
The patient was diagnosed with UES predominantly causing an inferior retinal detachment. He underwent right inferior sclerotomies 6 weeks later. Surgery involved performing 80% partial sclerotomy flaps of 7 × 5 mm with a central full thickness 1 × 2 mm sclerotomy in the inferior nasal and inferior temporal quadrants (Figure 2, Supplementary Video). The tissues demonstrated increased mucin along the interfibrillary space of scleral tissue, being consistent with UES (Figure 3).
Over the following 4 months, there was no significant improvement in the subretinal fluid (SRF) (Figure 1b) and the right visual acuity deteriorated to ‘Hand Movements’. The patient subsequently underwent sclerotomies, as described above, in the superior nasal and superior temporal quadrants. At 1 month postoperatively, the right visual acuity improved to 20/120. The choroidal effusions decreased, demonstrated by a reduction in the SRF (Figure 1c).
Comment
Our case highlights that even in cases of UES where there appears to be localised SRF, a sclerotomy in all four quadrants may be necessary. This reinforces the global nature of UES, as the localised SRF is likely to be inferior due to dependency. We suggest that sclerotomies may be required in four quadrants to decrease the overall resistance to choroidal fluid outflow thus facilitating drainage of fluid from the suprachoroidal and subretinal space.
References
Andrijevic Derk B, Bencic G, Corluka V, Zoric Geber M, Vatavuk Z . Medical therapy for uveal effusion syndrome. Eye 2014; 28: 1028–1031.
Elagouz M, Stanescu-Segall D, Jackson TL . Uveal effusion syndrome. Surv Ophthalmol 2010; 55: 134–145.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Eye website
Supplementary information
Rights and permissions
About this article
Cite this article
Wang, B., Clark, B., McKelvie, P. et al. Four quadrant sclerotomies for uveal effusion syndrome. Eye 29, 588–589 (2015). https://doi.org/10.1038/eye.2014.291
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2014.291
This article is cited by
-
Medical Therapy and Scleral Windows for Uveal Effusion Syndrome: A Case Series and Literature Review
Ophthalmology and Therapy (2023)
-
Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report
Journal of Medical Case Reports (2021)
-
Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’
Eye (2015)